Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib
Authors
Keywords
-
Journal
Biomolecules
Volume 12, Issue 11, Pages 1647
Publisher
MDPI AG
Online
2022-11-09
DOI
10.3390/biom12111647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How I Treat Relapsed Multiple Myeloma
- (2022) Efstathios Kastritis et al. BLOOD
- Diagnosis and Management of Multiple Myeloma
- (2022) Andrew J. Cowan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dietary Flavonoids with Catechol Moiety Inhibit Anticancer Action of Bortezomib: What about the other Boronic Acid-Based Drugs?
- (2022) Katrin Sak CURRENT CANCER DRUG TARGETS
- (−)-Epigallocatechin-3-gallate plays an antagonistic role in the antitumor effect of bortezomib in myeloma cells via activating Wnt/β-catenin signaling pathway
- (2022) Xi Qiu et al. Advances in Clinical and Experimental Medicine
- Polyphenols and Human Health: The Role of Bioavailability
- (2021) Chiara Di Lorenzo et al. Nutrients
- Oral ixazomib, lenalidomide, and dexamethasone for newly diagnosed transplant-ineligible multiple myeloma patients
- (2021) Thierry Facon et al. BLOOD
- Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds
- (2021) Abedul Haque et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib
- (2021) Vera Francisco et al. JOURNAL OF ETHNOPHARMACOLOGY
- Flavonoids: A Myth or a Reality for Cancer Therapy?
- (2021) Cinzia Forni et al. MOLECULES
- Treatment Options for Relapsed and Refractory Multiple Myeloma
- (2021) Samer Al Hadidi et al. JAMA Oncology
- Multiple Myeloma Inhibitory Activity of Plant Natural Products
- (2021) Karin Jöhrer et al. Cancers
- Nutraceuticals and Cancer: Potential for Natural Polyphenols
- (2021) Jessica Maiuolo et al. Nutrients
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment
- (2020) Heinz Ludwig et al. ONCOLOGIST
- Chemopreventive Property of Sencha Tea Extracts towards Sensitive and Multidrug-Resistant Leukemia and Multiple Myeloma Cells
- (2020) Xiaohua Lu et al. Biomolecules
- Multiple myeloma –Impact of induction therapy on transplant outcomes
- (2020) Lalit Kumar et al. Clinical Lymphoma Myeloma & Leukemia
- Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19
- (2020) M. Mrityunjaya et al. Frontiers in Immunology
- Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects
- (2020) Elia Pancheri et al. Cancers
- Selectivity of Current Extraction Techniques for Flavonoids from Plant Materials
- (2020) Milena Tzanova et al. Processes
- Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance
- (2020) Hardeep Singh Tuli et al. SEMINARS IN CANCER BIOLOGY
- A Practical Review of Proteasome Pharmacology
- (2019) Tiffany A. Thibaudeau et al. PHARMACOLOGICAL REVIEWS
- Isoginkgetin, a natural biflavonoid proteasome inhibitor, sensitizes cancer cells to apoptosis via disruption of lysosomal homeostasis and impaired protein clearance
- (2019) Jessica Tsalikis et al. MOLECULAR AND CELLULAR BIOLOGY
- Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma
- (2019) Junling Zhuang et al. BLOOD
- Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model
- (2019) Chulwon Kim et al. Biomolecules
- Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma
- (2019) Laura Rosiñol et al. BLOOD
- Medicinal prospects of antioxidants: A review
- (2019) Kumari Neha et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting multiple myeloma with natural polyphenols
- (2019) Fanny Pojero et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction
- (2019) Anthony R. M. Coates et al. Expert Review of Anti-Infective Therapy
- Attenuation of STAT3 Signaling Cascade by Daidzin Can Enhance the Apoptotic Potential of Bortezomib against Multiple Myeloma
- (2019) Min Hee Yang et al. Biomolecules
- Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments
- (2018) Jingping Hu et al. CANCER LETTERS
- Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
- (2018) Chulwon Kim et al. CANCER LETTERS
- Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
- (2018) Carlyn Rose C. Tan et al. CLINICAL PHARMACOKINETICS
- Food pyramid for subjects with chronic pain: foods and dietary constituents as anti-inflammatory and antioxidant agents
- (2018) Mariangela Rondanelli et al. NUTRITION RESEARCH REVIEWS
- Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade
- (2018) Young Yun Jung et al. Frontiers in Pharmacology
- Global Burden of Multiple Myeloma
- (2018) Andrew J. Cowan et al. JAMA Oncology
- Drug resistance in multiple myeloma
- (2018) Pawel Robak et al. CANCER TREATMENT REVIEWS
- Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
- (2018) Masturah Bte Mohd Abdul Rashid et al. Science Translational Medicine
- Scutellarein selectively targets multiple myeloma cells by increasing mitochondrial superoxide production and activating intrinsic apoptosis pathway
- (2018) Lin Shi et al. BIOMEDICINE & PHARMACOTHERAPY
- Reduction of SIRT1 epigenetically upregulates NALP1 expression and contributes to neuropathic pain induced by chemotherapeutic drug bortezomib
- (2018) Kun Chen et al. Journal of Neuroinflammation
- Proteasome inhibitors in cancer therapy
- (2017) Elisabet E. Manasanch et al. Nature Reviews Clinical Oncology
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple myeloma epidemiology and survival: A unique malignancy
- (2016) Dickran Kazandjian SEMINARS IN ONCOLOGY
- Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM)
- (2016) Daniele Tibullo et al. Nutrients
- Natural Polyphenols for Prevention and Treatment of Cancer
- (2016) Yue Zhou et al. Nutrients
- Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress
- (2015) Faisal Imam et al. Cardiovascular Toxicology
- New Targeted Drugs in Multiple Myeloma Therapy - in Vitro Studies
- (2015) C. Geraldes et al. Clinical Lymphoma Myeloma & Leukemia
- An in vitro and in vivo investigation of the cytotoxic effects of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester and bortezomib in multiple myeloma cells
- (2015) Ertan ALTAYLI et al. Turkish Journal Of Medical Sciences
- Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis
- (2015) Rong Fu et al. Oncotarget
- Natural compounds with anti-ageing activity
- (2013) Aikaterini Argyropoulou et al. NATURAL PRODUCT REPORTS
- Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1
- (2012) Subash C. Gupta et al. BIOCHEMICAL PHARMACOLOGY
- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea
- (2011) Bret Bannerman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells
- (2010) Sun-Hee Kim et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells
- (2009) Q. Wang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors
- (2009) E. B. Golden et al. BLOOD
- Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
- (2009) B. Sung et al. MOLECULAR CANCER THERAPEUTICS
- Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions
- (2009) M Reis-Sobreiro et al. ONCOGENE
- Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells
- (2008) Juwon Park et al. Molecular Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started